Abortion pill manufacturers are not fulfilling their obligation to oversee prescribers despite making tens of millions each year in profit, according to the findings of a monthslong investigation from Senate Republicans. 

A new investigation from Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy (R-LA) into the makers of the abortion drug mifepristone found the pharmaceutical companies may not be complying with safety oversight regulations.